Epimedium membranaceum
£7.50
Out of stock
Introduced from China by Mikinori Ogisu. This is an evergreen with new growth in early spring followed by bright yellow flowers. Leaves elongated and prickly. Flowers are borne in long racemes over a long flowering period from April to early August. Height to 45cm.
Be the first to review “Epimedium membranaceum”
Related products
Epimediums
In stock
Tough evergreen dappled-shade loving plant able to withstand dry conditions. Produces attractive mat of foliage and golden yellow flowers produced freely in spring.
Epimediums
In stock
Free-flowering herbaceous form with sulpher yellow flowers over bronzed foliage in early spring. Plant in light shade, away from summer drought and winter waterlogging, but water in well in its first year.
Epimediums
Feb 2023
Epimedium x-rubrum. Spreading evergreen perennial. Red and lemon flowers over fresh red-hued leaves in early spring. Plant in light shade, away from summer drought and winter waterlogging, but water in well in its first year. (photograph courtesy of Danielle Monbaliu)
Epimediums
Nov 2022
New evergreen hybrid with unusual deep red-purple flowers in spring. Humus rich soil with some shade. Only one order per customer please.
Epimediums
Nov 2022
Evergreen Chinese woodlander, with red flowers amongst numerous small leaves up to 35cm high. Plant in light shade, away from summer drought and winter waterlogging, but water in well in its first year. Available in very limited numbers only.
Epimediums
November 2022
Free-flowering evergreen form with two-tone bright yellow flowers. Plant in light shade, away from summer drought and winter waterlogging, but water in well in its first year. Raised by Desirable Plants.
Epimediums
Nov 2021
Pink nodding backswept flowers in spring. Evergreen foliage. Humus rich shade
Epimediums
November 2022
Distinct American hybrid. Clear yellow flowers over holly-like leaves. Plant in light shade, away from summer drought and winter waterlogging, but water in well in its first year.
Reviews
There are no reviews yet.